• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Recent Advances in the Study of N-[(3S)-pyrrolidin-3-yl]acetamide Hydrochloride (CAS: 1246277-44-0)

N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride (CAS: 1246277-44-0) is a chiral pyrrolidine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique stereochemistry and functional groups, has shown promising potential in various therapeutic applications, particularly in the modulation of neurological and metabolic pathways. Recent studies have focused on its synthesis, pharmacological properties, and potential clinical applications, making it a subject of intense scientific scrutiny.

The synthesis of N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride has been optimized to achieve high enantiomeric purity, which is critical for its biological activity. Researchers have employed asymmetric synthesis techniques, including chiral auxiliary-assisted methods and enzymatic resolution, to obtain the desired (3S)-configuration. These advancements have not only improved the yield and scalability of the synthesis but also facilitated the production of derivatives for structure-activity relationship (SAR) studies.

Pharmacological investigations have revealed that N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride exhibits notable activity as a modulator of neurotransmitter systems. Specifically, it has been shown to interact with nicotinic acetylcholine receptors (nAChRs) and dopamine receptors, suggesting potential applications in the treatment of neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease. Additionally, its role in modulating insulin signaling pathways has sparked interest in its use for metabolic disorders, including type 2 diabetes.

Recent preclinical studies have demonstrated the compound's efficacy in animal models of neurological and metabolic diseases. For instance, in a murine model of Parkinson's disease, administration of N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride resulted in significant improvements in motor function and reduced dopaminergic neuron loss. Similarly, in diabetic models, the compound enhanced glucose uptake and insulin sensitivity, highlighting its dual therapeutic potential.

Despite these promising findings, challenges remain in the clinical translation of N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride. Issues such as bioavailability, pharmacokinetics, and potential off-target effects need to be addressed through further research. Current efforts are focused on optimizing the compound's formulation and delivery systems to enhance its therapeutic index. Collaborative studies between academic institutions and pharmaceutical companies are underway to accelerate its development.

In conclusion, N-[(3S)-pyrrolidin-3-yl]acetamide hydrochloride represents a versatile and pharmacologically active compound with broad therapeutic potential. Ongoing research aims to elucidate its mechanisms of action, refine its synthesis, and explore its clinical applications. As the scientific community continues to uncover its multifaceted roles, this compound is poised to make significant contributions to the fields of neurology and metabolic medicine.

• 345347-89-9(N-(S)-1-Pyrrolidin-2-ylmethyl-acetamide)
• 1624261-23-9(N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride)
• 79286-74-1(N-(pyrrolidin-3-yl)acetamide)
• 139024-74-1(Acetamide, N-(3,4-diaminobutyl)-, hydrochloride (1:2))
• 131900-62-4(N-[(3R)-pyrrolidin-3-yl]acetamide)
• 114636-31-6(N-[(3S)-pyrrolidin-3-yl]acetamide)
• 1354003-41-0(N-[(R)-1-(2-Amino-ethyl)-pyrrolidin-3-yl]-acetamide)
• 1249159-54-3(N-(pyrrolidin-2-yl)methylacetamide)
• 1342378-51-1(N-[1-(Aminomethyl)propyl]acetamide)
• 76753-37-2(3-Acetamidopyrrolidine)